Abbott (NYSE:ABT) shares are down nearly 2% this morning on Wall Street, after the company’s 4th-quarter sales missed expectations.
The medical products giant posted revenues of $10.38 billion for the 3 months ended Dec. 31, 2011, up 4.1% compared with Q4 2010 but lower than the $10.63 billion expected on The Street.
ABT shares were trading at $55.02 as of about 11 a.m. today, down 1.7%, despite Street-beating profit numbers for both the quarter and the full year.